Literature DB >> 8187085

Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas.

I Bongarzone1, M G Butti, S Coronelli, M G Borrello, M Santoro, P Mondellini, S Pilotti, A Fusco, G Della Porta, M A Pierotti.   

Abstract

Tumor specific rearrangements of ret gene are frequently detected in papillary thyroid carcinomas. These rearrangements result in the formation of chimeric genes showing the tyrosine kinase domain of ret fused with the 5' end sequences of different genes. We examined a series of 52 patients and identified 10 cases of ret fusion with D10S170 locus resulting in the generation of ret/PTC1 oncogene, 2 cases with the gene encoding the regulatory subunit RI alpha of PKA (ret/PTC2), and finally 6 cases, here described, with a newly discovered gene called ele1 localized on chromosome 10 and leading to the formation of ret/PTC3 oncogene. Our results show the expression of the ret/PTC3 hybrid gene in all the 6 cases and demonstrated its association with the synthesis of 2 constitutively phosphorylated isoforms of the oncoprotein (p75 and p80). The chromosome 10 localization of both ret and ele1 and the detection, in all cases, of a sequence reciprocal to that generating the oncogenic rearrangements, strongly suggest that ret/PTC3 formation is a consequence of an intrachromosomal inversion of chromosome 10.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8187085

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations.

Authors:  Ludovic Lacroix; Vladimir Lazar; Stefan Michiels; Hugues Ripoche; Philippe Dessen; Monique Talbot; Bernard Caillou; Jean-Pierre Levillain; Martin Schlumberger; Jean-Michel Bidart
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

2.  A Drosophila model of multiple endocrine neoplasia type 2.

Authors:  Renee D Read; Paul J Goodfellow; Elaine R Mardis; Nancy Novak; Jon R Armstrong; Ross L Cagan
Journal:  Genetics       Date:  2005-06-18       Impact factor: 4.562

3.  Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma.

Authors:  Krystian Jazdzewski; Elizabeth L Murray; Kaarle Franssila; Barbara Jarzab; Daniel R Schoenberg; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-12       Impact factor: 11.205

4.  Prevalence of RET/PTC1 and RET/PTC3 gene rearrangements in Chennai population and its correlation with clinical parameters.

Authors:  P Jagan Mohan Rao; N V Vardhini; M V S Parvathi; P Balakrishna Murthy; G Sudhakar
Journal:  Tumour Biol       Date:  2014-06-24

Review 5.  The RET proto-oncogene: a challenge to our understanding of disease pathogenesis.

Authors:  T Kusafuka; P Puri
Journal:  Pediatr Surg Int       Date:  1997       Impact factor: 1.827

6.  Shc and Enigma are both required for mitogenic signaling by Ret/ptc2.

Authors:  K Durick; G N Gill; S S Taylor
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

7.  Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70.

Authors:  Yi Peng; Caihong X Li; Fei Chen; Zhengxin Wang; Martin Ligr; Jonathan Melamed; Jianjun Wei; William Gerald; Michele Pagano; Michael J Garabedian; Peng Lee
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

8.  Overexpression of leucocyte common antigen (LAR) P-subunit in thyroid carcinomas.

Authors:  N Konishi; K Tsujikawa; H Yamamoto; E Ishida; M Nakamura; K Shimada; K Yane; H Yamashita; S Noguchi
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

9.  RET/PTC rearrangements arising from a small population of papillary thyroid carcinoma cells, possible candidate for passenger mutation.

Authors:  Tadao Nakazawa; Shin-ichi Murata; Tetsuo Kondo; Dongfeng Niu; Kunio Mochizuki; Tomonori Kawasaki; Tetsu Yamane; Nobuki Nakamura; Ryohei Katoh
Journal:  Virchows Arch       Date:  2009-06-03       Impact factor: 4.064

Review 10.  Modeling thyroid cancer in the mouse.

Authors:  X-G Zhu; S-Y Cheng
Journal:  Horm Metab Res       Date:  2009-04-08       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.